Hendra Zufry
Divisi Endokrin Metabolik Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Syah Kuala, Banda Aceh, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Korelasi Derajat Graves’ Ophthalmopathy dengan Durasi Menderita Hipertiroid Jonny Karunia Fajar; Cut Intan Hidayah; Lia Meuthia Zaini; Hendra Zufry; Jamhur -
Cermin Dunia Kedokteran Vol 42, No 5 (2015): Kardiologi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v42i5.1006

Abstract

Graves’ ophthalmopathy merupakan penyakit autoimun. Studi ini bertujuan untuk mengetahui distribusi manifestasi klinis Graves’ ophthalmopathy dan mengetahui kaitan lama menderita hipertiroid dengan derajat keparahan Graves’ ophthalmopathy. Penelitian ini merupakan penelitian observasional analitik dengan 34 sampel penderita Graves’ ophthalmopathy. Data dianalisis menggunakan uji Spearman. Hasil penelitian ini menunjukkan bahwa distribusi manifestasi klinis penderita Graves’ ophthalmopathy di poliklinik endokrin RSUZA adalah 23,5% derajat 0; 8,8% derajat 1; 14,7% dengan derajat 2; 14,7% derajat 3; 11,7% derajat 4; 20,5% derajat 5; dan 5,8% derajat 6. Terdapat asosiasi signifikan antara lama menderita hipertiroid dengan derajat Graves’ ophthalmopathy (p=0,000). Kebanyakan penderita Graves’ ophthalmopathy memiliki manifestasi klinis derajat 0 dan lama menderita hipertiroid berbanding lurus dengan tingkat keparahan Graves’ ophthalmopathy.Graves’ ophthalmopathy is an autoimmune disease. The aim of this study is to determine the characteristic of the clinical manifestations of Graves’ ophthalmopathy and the association between duration of hyperthyroidism and the degree of Grave’s ophthalmopathy. It is an analytical observational study in 34 patients with Graves’ ophthalmopathy. Data were analyzed using the Spearman test. It showed that 23.5% of the patients were in stage 0; 8.8% were in stage 1; 14.7% were in stage 2; 14.7% were in stage 3; 11.7% were in stage 4; 20.5% were in stage 5; and 5.8% were in stage 6. There was a significant association between the degree of Graves’ ophthalmopathy and duration of hyperthyroidism. Majority of the patients with Graves’ ophthalmopathy had clinical manifestation of stage 0 and the duration of hyperthyroidism was significantly associated with the severity of Graves’ ophthalmopathy.